Macquarie US SmallCap A (terminated)

Profile

Maquarie US SmallCap was terminated on Tuesday the 18th of June 2019 by the end of the day. More information can be found under the section Documents / Other on the Dutch part of the website.

This strategy mainly invested in (certificates of) shares of companies that are listed on the Canadian or US stock exchanges or where the majority of their activities take place in these countries. In addition, the strategy also preserved the possibility of investing in other instruments, including exchange traded funds (ETFs). The investment policy of the strategy was focused on selecting stocks and putting together a portfolio consisting of small and medium-sized listed companies. Macquarie US SmallCap focused on realizing long-term value growth. The Fund was actively managed.

Management team

Delaware Investment Advisers

Performance per 2019-05-31

Slide to see more
  Fund
1 month -7.4 %
3 months -3.2 %
This year 12.8 %
2016 2.3 %
2017 -0.5 %
2018 -7.2 %
1 year (on annual basis) -4.7 %
Since inception (on annual basis) i 3.4 %
More information can be found on the documents page of this fund

Key figures

Slide to see more
Total fund size
EUR 10.33 M 2019-05-31
Share class size
EUR 10.33 M 2019-05-31
Number of shares
379,675 2019-05-31
Net Asset Value i
EUR 28.34 2019-06-18
Transaction price i
EUR 27.72 2019-06-05
Macquarie US SmallCap (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Delaware Investment Advisers. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
Macquarie US SmallCap (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Delaware Investment Advisers. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.

Performance per 2019-05-31

Slide to see more
  Fund
1 month -7.4 %
3 months -3.2 %
This year 12.8 %
2016 2.3 %
2017 -0.5 %
2018 -7.2 %
1 year (on annual basis) -4.7 %
Since inception (on annual basis) i 3.4 %

Dividends

Slide to see more
Distributing
No
Macquarie US SmallCap (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Delaware Investment Advisers. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.

Top 8 holdings (2019-05-31)

1.7 %
Northwestern Corp
1.6 %
Spire Inc.
1.6 %
Q2 HOLDINGS INC
1.5 %
ESSENT GROUP LTD
1.4 %
MGIC INVESTMENT CORP
1.3 %
REPLIGEN CORP
1.3 %
SOUTH JERSEY INDUSTRIES
1.3 %
J2 GLOBAL INC
Total
11.8 %
Macquarie US SmallCap (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Delaware Investment Advisers. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.

Ongoing charges

Slide to see more
Ongoing charges last financial year i
1.37 %
The Ongoing Charges Figure of the last financial year relates to 2018.

Other costs

Slide to see more
Upward swing factor i
0.35 %
Downward swing factor i
0.35 %
Macquarie US SmallCap (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Delaware Investment Advisers. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.

Share class details

Slide to see more
Share class
A i
Investor type
Institutional & Private
Distributing
No
Benchmark i
MSCI North American Index
Duration hedged
No
Investment category
Other
Universum
Small-& Mid-caps Worldwide
Inception date
2016-10-21
Domicile
The Netherlands
May be offered to all investors in
The Netherlands
UCITS status i
No
Status
Open-end i
Base currency
EUR
Share class currency
EUR
Administrator
BNP Paribas Securities Services S.C.A.
Auditor
PricewaterhouseCoopers Accountants N.V.
Transfer agent
Van Lanschot N.V.
Management company
Kempen Capital Management N.V.
Depositary and custodian
BNP Paribas Securities Services S.C.A.

Tradability

Slide to see more
Listed
no
Subscription/Redemption Frequency
Daily
ISIN i
NL0011983341
Macquarie US SmallCap will only be available for orders submitted via the Transfer Agent platform of F. van Lanschot Bankiers N.V. Participations will only be available for distributors who submit orders on behalf of their clients, and who have been selected by the management company.
Macquarie US SmallCap (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Delaware Investment Advisers. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
Macquarie US SmallCap (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Delaware Investment Advisers. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
No data available.
Macquarie US SmallCap (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Delaware Investment Advisers. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.

The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are availableon the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.